Home > Online Continuing Education
Online Continuing Education
Earn CE credit at your leisure and stay abreast of the clinical updates in the field of. HIV, HCV and STDs. We deliver high-quality continuing medical educational activities developed by clinicians and leading researchers in the specified area. Our CE activities are all free and can be taken at any time from any Internet-connected computer.
-
David Boulware, MD, MPH, CTropMed
Lois & Richard King Distinguished Assistant Professor
University of Minnesota
Presentation Date: 06/19/2012
Release Date: 02/01/2013
Learning Objectives
- Recognize risk factors for immune reconstitution inflammatory syndrome (IRIS).
- Distinguish IRIS from other mimics.
- Understand clinical management and treatment of IRIS.
Presenter Bio
Dr. Boulware serves as the Associate Director of Global Health Programs in Internal Medicine at the University of Minnesota, and his research interest is in understanding the pathogenesis of HIV immune reconstitution inflammatory syndrome (IRIS). In particular, Dr. Boulware is most interested in translational research of disease pathogenesis leading to practical clinical interventions to improve outcomes. In collaboration with investigators at Makerere University and Mbarara University in Uganda, and at the University of Cape Town, in South Africa, Dr Boulware is working to improve the survival of persons with cryptococcal meningitis by identifying the optimal time to start HIV therapy after meningitis (NCT01075152). Through this trial, Dr.Boulware’s collaborative research involves characterizing the differences in immune responses that occur over time among people who develop IRIS, in an effort to identify the pathophysiology of IRIS, identify biomarkers for the prediction and diagnosis of IRIS, develop better treatments, and to prevent IRIS.
Continuing Education Credit
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on June 19, 2012
and will terminate June, 2015.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Saurabh Mehandru, MD
Assistant Professor; Visiting Scientist, The Aaron Diamond AIDS Research Center
Mount Sinai School of Medicine
Presentation Date: 06/19/2012
Release Date: 02/01/2013
Learning Objectives
- Understand the functional and anatomic organization of the GI immune system and its relevance to the pathogenesis of HIV-1 infection.
- Appreciate the impact of acute and chronic HIV-1 on the GI immune system.
- Know the effect of prolonged antiretroviral therapy on GI immune reconstitution and its potential clinical implications.
Presenter Bio
Saurabh Mehandru is an Assistant Professor of Gastroenterology at the Mount Sinai School of Medicine in New York City. Saurabh’s research interests include study of the gastrointestinal immune system in HIV infection. He trained at the Aaron Diamond AIDS Research Center in the laboratory of Dr. Martin Markowitz where he described the early and preferential depletion of GI CD4+ T cells during acute HIV infection and the incomplete reconstitution of intestinal CD4 T cells with ART. Saurabh then worked in the laboratory of Dr. Ralph Steinman, where using novel HIV vaccines, he focused on the generation of intestinal immunity against HIV.
Continuing Education Credit
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on June 19, 2012
and will terminate June, 2015.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Christina Wyatt, MD
Assistant Professor of Medicine, Department of Nephrology
Mount Sinai School of Medicine, New York, NY
Presentation Date: 05/23/2012
Release Date: 01/10/2013
Learning Objectives
- Identify HIV-infected individuals who may be at higher risk for kidney disease.
- Recognize the limitations of current screening tests for kidney disease and nephrotoxicity in HIV-infected individuals.
- Understand the diagnosis and management of ART nephrotoxicity.
Presenter Bio
Christina Wyatt’s clinical and research interests focus on acute and chronic kidney disease in patients with HIV and hepatitis C. Ongoing projects include a prospective research cohort in Mount Sinai's active HIV practice, as well as two studies investigating the utility of currently available GFR estimates in patients with HIV infection. Study objectives in the HIV cohort include description of the prevalence, incidence, and predictors of acute and chronic kidney disease in the era of antiretroviral therapy, as well as improved understanding of the impact of HCV co-infection on the risk for kidney disease.
Continuing Education Credit
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on May 23, 2012
and will terminate May, 2015.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Samir Gupta, MD, MS
Associate Professor of Medicine, Division of Infectious Diseases
Indiana University School of Medicine
Presentation Date: 05/23/2012
Release Date: 01/09/2013
Learning Objectives
- Compare the epidemiology of cardiovascular disease in those with and without HIV infection.
- Differentiate the contributions of HIV medications vs. the infection itself on cardiovascular disease.
- Predict which interventions may reduce the increased risk of cardiovascular disease in HIV-infected patients.
Presenter Bio
Samir Gupta is an HIV care provider at the Wishard Memorial Hospital (the county hospital for Indianapolis) and has participated in clinical research focusing on the effects of HIV and ART on renal and cardiovascular diseases. Dr. Gupta receives funding from both the NIH and industry to support these ongoing research efforts. In particular, Dr. Gupta is the Principal Investigator for one of the NIH-CVD collaborative research programs.
Continuing Education Credit
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on May 23, 2012 and will terminate May, 2015.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Pablo Tebas, MD
Director, AIDS Clinical Trials Unit (ACTU)
University of Pennsylvania
Presentation Date: 04/24/2012
Release Date: 09/27/2012
Learning Objectives
- Know the different gene therapy approaches that are being taken to treat HIV infection and the role of zinc finger nucleases.
- Discuss the potential side effects of these approaches.
- Understand other potential strategies beyond gene therapy to control HIV in the absence of antiretroviral therapy.
Presenter Bio
Pablo Tebas directs the adult AIDS Clinical Trials Unit (ACTU) of the University of Pennsylvania. His main research interests are the treatment of HIV infection and the study of the metabolic complications associated with HIV infection and its treatment The introduction of highly active antiretroviral therapy has resulted in significant reductions in the morbidity and mortality associated with HIV infection. Unfortunately, the use of HAART has also been associated with significant adverse effects, including dyslipidemia and insulin resistance, bone disease and fat redistribution. Current studies are directed to understand better the mechanisms of these complications and prevent their development. Current outpatient and inpatient clinical activities center in the Hospital of the University of Pennsylvania where he follows general ID and HIV infected patients.
Continuing Education Credit
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on April 24, 2012 and will terminate April, 2015.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Gero Hütter, MD
Production Manager, Institute of Transfusion Medicine and Immunology
Heidelberg University, Mannheim, Germany
Presentation Date: 04/24/2012
Release Date: 09/24/2012
Learning Objectives
- Understand the strategy of stem cell transplantation in HIV patients.
- Know the importance of CCR5 for maintaining HIV infection.
- Discuss the topics of functional and sterilizing cure.
Presenter Bio
Gero Hütter developed and performed the first allogeneic bone marrow transplantation with natural CCR5 depleted stem cells in a leukemia patient with HIV-infection in 2004, during his residency in hematology, oncology and transfusion medicine at Charité Hospital in Berlin, Germany. Since then, Timothy Brown, now known as “the Berlin patient,” has not resumed antiretroviral therapy, nor has he had a relapse of HIV disease. In 2009 Dr Hütter became the head of the stem cell unit of the Institute of Transfusion Medicine and Immunology Mannheim of the Heidelberg University. There, he directs the research group for personalized stem therapy, which is supported by a grant from the Bill & Melinda Gates foundation.
Continuing Education Credit
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on April 24, 2012 and will terminate April, 2015.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Angela Kashuba, BScPhm, PharmD, DABCP
Associate Professor
University of North Carolina School of Pharmacy
Presentation Date: 03/27/2012
Release Date: 07/20/2012
Learning Objectives
- Review the completed and ongoing clinical trials that use antiretroviral agents for HIV prevention.
- Outline potential reasons for the current discrepant clinical trial results.
- Discuss agents and modes of delivery currently in the HIV prevention pipeline.
- Review future strategies and optimal clinical trial designs for HIV chemoprophylaxis.
Presenter Bio
Angela Kashuba has been on faculty at the University of North Carolina at Chapel Hill since 1997, and is currently an Associate Professor in the UNC School of Pharmacy, and directs both the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core and the Pharmacology Core for the UNC Delaney Collaboratory. She is a Diplomate of the American Board of Clinical Pharmacology and was the 2009 recipient of the Leon I. Goldberg Young Investigator Award from the American Society of Clinical Pharmacology and Therapeutics. Dr. Kashuba has authored over 110 publications and has received ~$12 million in research funding. Her research is focused on utilizing antiretrovirals to prevent HIV transmission, and she is currently involved in evaluating drug concentration-effect relationships in CAPRISA 004 and FEMPrEP.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on March 27, 2012 and will terminate March, 2015.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Roy Gulick, MD, MPH
Professor of Medicine and Chief of the Division of Infectious Diseases
Weill Medical College of Cornell University in New York City
Presentation Date: 03/27/2012
Release Date: 07/20/2012
Learning Objectives
- Understand the evolving recommendations for when to start antiretroviral therapy (ART) for HIV disease.
- Identify optimal initial ART regimens.
- Know strategies for treatment-experienced patients.
- Learn about new antiretroviral agents for the treatment of HIV disease.
Presenter Bio
Dr. Gulick is Professor of Medicine and Chief of the Division of Infectious Diseases at Weill Medical College of Cornell University in New York City. He currently serves as Principal Investigator of the Cornell HIV Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG), sponsored by the National Institutes of Health. He also serves as a Board Member of the International AIDS Society-USA, and as a member of the Panel on Clinical Practices for Treatment of HIV Infection of the U.S. Department of Health and Human Services.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on March 27, 2012 and will terminate March, 2015.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Thomas Cherneskie, MD, MPH
Supervising Physician
NYC Department of Health & Mental Hygiene
Presentation Date: 02/28/2012
Release Date: 07/20/2012
Learning Objectives
- Make better use of sexual history in the examination of oral, anogenital, skin and systemic complaints of patients with or at risk for HIV disease.
- Understand the differential diagnosis and appropriate diagnostic studies in evaluation of skin, oral and anogenital lesions suggestive of sexually transmitted infections.
- Know preferred treatments of common STIs, and appropriate partner notification and follow-up.
- Better counsel patients on the relative risk of concomitant HIV transmission associated with other STIs.
Presenter Bio
THOMAS CHERNESKIE is a graduate of the Penn State College of Medicine, following which he continued his training in Family Medicine and more recently Preventive Medicine & Public Health, obtaining an Master in Public Health from the Columbia University Mailman School of Public Health. His practice history includes outpatient urban primary care, occupational medicine, and currently serves as the supervising physician at one of NYC Department of Health & Mental Hygiene’s Sexual Health Clinics. He has nearly 15 yrs. of experience in the field of Sexually transmitted diseases and continues to share his expertise as a faculty member, and founding Medical Director, of the Region II CDC-funded STD/HIV Prevention Training Center.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on February 28, 2012 and will terminate February, 2015.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
N. Hennessey, MD
Associate Clinical Professor
NYU School of Medicine
Presentation Date: 02/28/2012
Release Date: 07/20/2012
Learning Objectives
- Recognize the dermatological signs of acute HIV.
- Be more familiar with common dermatological presentations in chronic and advanced HIV disease.
- Understand primary-care diagnosis and treatment approaches to common HIV-related dermatological problems, and when to refer to a specialist.
Presenter Bio
PATRICK HENNESSEY is an associate clinical professor at the NYU School of Medicine, with additional teaching appointments at SUNY Downstate & the New York College of Osteopathic Medicine. Dr. Hennessey is a member of the medical staffs of NYU Tisch, Long Island College & Southampton Hospitals with private practices in New York City & the Hamptons. Dr. Hennessey graduated from Michigan State University College of Human Medicine with residencies in medicine at New England Deaconness Hospital in Boston and dermatology at New York University Medical Center. Dr. Hennessey also completed a post graduate fellowship in malignant melanoma and has continued his interest in cutaneous malignancies and HIV-related skin diseases with over 25 publications in these areas.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on February 28, 2012 and will terminate February, 2015.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Davey Smith, MD, MAS
Medical Director, Early Intervention Program
University of California San Diego
Presentation Date: 12/13/2011
Release Date: 07/20/2012
Learning Objectives
- Know the differences between HIV-1 co-infection and superinfection.
- Understand who might be at risk for superinfection.
- Discuss what superinfection might mean clinically.
- Realize what superinfection might mean for preventive vaccine efforts.
Presenter Bio
Davey Smith is a translational research virologist. He uses basic science techniques to answer clinically relevant questions and vice-versa. He works both at the UCSD Antiviral Research Center where he is the medical director of the Early Intervention Program and in his laboratory on the UCSD campus where he performs bench research and he runs the Centers for AIDS Research Translational Virology Core. His primary research focus is on the transmission of HIV, including HIV superinfection and characterizing HIV shed from the genital tract. These studies are in pursuit to understand the correlates that drive HIV transmission and find new ways to interrupt them. In October, 2010, Dr. Smith was named HIV Researcher of the Year by the HIV Medical Association.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on December 13, 2011 and will terminate December, 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Todd Brown, MD, PhD
Associate Professor of Medicine
Johns Hopkins University
Presentation Date: 12/13/2011
Release Date: 07/20/2012
Learning Objectives
- Discuss the optimal screening recommendations regarding hypogonadism and the current controversies.
- Discuss the potential risks and benefits of testosterone therapy, particularly with respect to the older male.
Presenter Bio
Todd T. Brown is an Associate Professor of Medicine in the Division of Endocrinology and Metabolism at Johns Hopkins University where he is also the primary endocrine consultant to the Johns Hopkins HIV Clinic. His research focuses on metabolic, endocrine, and skeletal abnormalities observed in HIV-infected patients, particularly as related to aging. Dr Brown is Chair of the Metabolic Working Group in the Multicenter AIDS Cohort Study and was appointed by the AIDS Clinical Trial Group to their newly formed Inflammation/End-organ Disease Transformative Science Group.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on December 13, 2011 and will terminate December, 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Donald Kotler, MD
Chief, Division of Gastroenterology and Liver Disease
St. Luke's-Roosevelt
Presentation Date: 11/15/2011
Release Date: 07/20/2012
Learning Objectives
- Describe the heterogeneity of the HIV-infected population of New York City and its varied effects on GI disease.
- Review the clinical manifestations of HIV-associated and selected non-HIV associated GI diseases that affect our patients.
- Utilize algorithms for the evaluation of specific clinical GI syndromes.
Presenter Bio
Donald P. Kotler is a gastroenterologist, an expert on GI manifestations of HIV disease, and a pioneer in the study of the AIDS wasting syndrome. Dr. Kotler has concentrated on the study of body composition in order to define the characteristics of malnutrition in HIV infection and other diseases, as well as strategies to reverse the wasting process. He has been the Principal investigator on single-site and multi-center studies of nutritional therapies for HIV-associated malnutrition. In addition, Dr. Kotler has studied the opportunistic enteric complications of AIDS as well as the role of HIV as an enteric pathogen. More recently, he has studied the body composition and metabolic abnormalities associated with lipodystrophy, and is applying his knowledge and laboratory techniques to the study of chronic liver disease.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on November 15, 2011 and will terminate November, 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Andrew Talal, MD, MPH
Associate Medical Director
Center for the Study of Hepatitis C at the Weill Cornell Medical College
Presentation Date: 10/11/2011
Release Date: 06/29/2012
Learning Objectives
- Understand the current approach to the diagnosis and staging of hepatitis C virus (HCV) infection.
- Know how HIV/HCV coinfection affects HCV pathogenesis.
- Appreciate treatment outcomes and side effect management to pegylated interferon and ribavirin in both HCV monoinfected and HIV/HCV coinfected individuals.
Presenter Bio
Andrew Talal is Associate Professor of Medicine and Associate Medical Director at the Center for the Study of Hepatitis C at the Weill Cornell Medical College. Following his research fellowship in Gastrointestinal Epidemiology at the University of North Carolina at Chapel Hill, Dr Talal became a Rockefeller University Clinical Scholar in the laboratory of Dr. David Ho where he investigated the pathogenesis of HIV in the gut associated lymphoid tissue. In February 2000, Dr. Talal joined the faculty at Weill Cornell where he founded the Viral Hepatitis Clinic, the Center’s Translational Research Laboratory. His research interests include investigation of chemokines as mediators of fibrogenesis and noninvasive biomarkers of hepatic fibrosis. He also has been interested in HCV management in disenfranchised populations including HIV/HCV coinfected and those on opiate agonist therapy.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on October 11, 2011 and will terminate October, 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Charles Flexner, MD
Professor of Medicine and Pharmacology
Johns Hopkins University School of Medicine
Presentation Date: 10/11/2011
Release Date: 06/29/2012
Learning Objectives
- Know the clinical importance of pharmacologic factors in the management and control of HCV infection with and without HIV-coinfection.
- Understand possible approaches to managing clinically significant drug-drug interactions involving new directly-acting agents (DAA) for HCV.
- Discuss similarities and differences in the pharmacologic management of hepatitis virus infections as compared to HIV.
Presenter Bio
Charles W. Flexner is Professor of Medicine in the Divisions of Clinical Pharmacology and Infectious Diseases, and Professor of Pharmacology and Molecular Sciences in the Johns Hopkins University School of Medicine. He is also Professor of International Health in the Johns Hopkins University Bloomberg School of Public Health. Dr. Flexner is an acknowledged expert on the basic and clinical pharmacology of drugs for HIV/AIDS and related infections, including viral hepatitis and tuberculosis. His scientific contributions include work on the important roles of pharmacokinetic enhancement, adherence, and dosing frequency in the long-term management of HIV/AIDS. He has also published extensively on anti-infective drug transport and metabolism, and metabolic drug interactions. Dr. Flexner is the Principal Investigator of the Johns Hopkins University AIDS Clinical Trials Unit (ACTU) supported by the NIH, and is Chair of the AIDS Clinical Trials Group (ACTG) Translational Research and Drug Development (TRADD) Committee.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on October 11, 2011 and will terminate October, 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Marion Peters, MD
ACTG Hepatitis Transformative Science Group
Presentation Date: 09/13/2011
Release Date: 06/29/2012
Learning Objectives
- Understand how to diagnose and treat HBV coinfection in HIV-positive patients.
- Know the causes of HBV reactivation in HIV coinfected patients.
- Monitor and manage end-stage liver disease in HBV- and HIV-infected patients.
Presenter Bio
Marion Peters, MD, is a hepatologist who is particularly interested in viral hepatitis. She has performed many studies of HBV infection, most recently the knowledge and screening among family members of Hepatitis B infected Asians in San Francisco. She leads the ACTG Hepatitis Transformative Science Group and the Women’s Interagency HIV study (WIHS) Hepatitis Working Group. She is studying new serum markers to evaluate liver fibrosis in WIHS. She is particularly interested in studying outcomes in Hepatitis B and new HCV drugs for patients with HCV, with and without HIV.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on September 13, 2011 and will terminate September, 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Michelle Roland, MD
Chief of the Office of AIDS
California Department of Health
Presentation Date: 09/13/2011
Release Date: 06/29/2012
Learning Objectives
- Know the patient and graft outcomes among 150 HIV-positive kidney recipients followed prospectively, including the challenges with transplant rejection and management of drug interactions and potential nephrotoxicities.
- Understand predictors of mortality and implications for patient selection among 125 HIV-positive liver transplant recipients.
- Discuss HIV-specific outcomes and predictors among the entire cohort of 275 HIV-positive liver and kidney recipients, all followed for a minimum of 1 year.
Presenter Bio
Michelle Roland, MD, is Chief of the Office of AIDS, California Department of Health, and Associate Clinical Professor of Medicine in the Department of Medicine, UCSF Positive Health Program (HIV/AIDS Division) at San Francisco General Hospital. In addition to her leadership in non-occupational post-exposure prophylaxis research, Dr Roland developed and implemented pilot studies that led to an NIH-funded, 21-center study of kidney and liver transplantation in people living with HIV, for which she served as co-principle investigator and lead HIV physician.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on September 13, 2011 and will terminate September, 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Stephen Goldstone, MD, FACS
Assistant Clinical Professor of Surgery
Mount Sinai School of Medicine
Presentation Date: 08/09/2011
Release Date: 06/25/2012
Learning Objectives
- Understand important history-taking questions to aid in diagnosing common anorectal disorders in MSM.
- Identify common anorectal disorders during physical examination in MSM.
- Understand the best treatment options for common anorectal disorders in MSM.
Presenter Bio
Stephen Goldstone, MD, FACS is an Assistant Clinical Professor of Surgery at the Mount Sinai School of Medicine and has a surgical practice in New York City. He has developed a surgical technique to treat anal HPV dysplasia and is a member of the AIDS Malignancy Consortium. Dr. Goldstone is an expert on gay men's health, and has done extensive research on human papillomavirus (HPV), including prevention and treatment procedures for HPV.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on August 9, 2011 and will terminate August, 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Joel Palefsky, MD, CM, F.R.C.P.(C)
Professor of Medicine
University of California San Francisco School of Medicine
Presentation Date: 08/09/2011
Release Date: 06/25/2012
Learning Objectives
- Understand the epidemiology of anal cancer in the post-ART era.
- Understand current approaches to anal cancer screening and their limitations.
- Understand the role of HPV vaccination in anal cancer prevention.
Presenter Bio
Dr. Joel Palefsky is a Professor of Medicine at the University of California San Francisco School of Medicine, and an expert on the molecular biology, treatment, pathogenesis and natural history of anogenital human papillomavirus infections, particularly in the setting of HIV infection. He is the Director of the world's first clinic devoted to prevention of anal cancer, the Anal Neoplasia Clinic at the UCSF Cancer Center, and chair of the HPV Working Group of the U.S. National Cancer Institute-supported AIDS Malignancy Consortium. He is the founder of the newly established International Anal Neoplasia Society and is the president-elect of the International Papillomavirus Society.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on August 9, 2011 and will terminate August, 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Tanya Zangaglia, M.D.
Medical Director
Project Streetbeat
Presentation Date: 06/08/2012
Release Date: 06/08/2012
Learning Objectives
- State that near perfect adherence (>90-95%) is the goal for HIV – infected patients.
- Identify at least three factors related to adherence.
- Identify three potential barriers to adherence.
- State the importance of discussion of adherence & the development of antiretroviral resistance with clients.
Presenter Bio
Dr. Zangaglia is the Medical Director for Project Streetbeat as well as a Lecturer for the AIDS Education & Training Centers and Clinical Education Initiative (CEI).
Continuing Education Credit
The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians. School of Public Health, University at Albany designates this online course for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
School of Public Health, University at Albany is an approved provider of continuing nursing education by the Massachusetts Association of Registered Nurses, Inc., an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
-
Sally Friedman, Esq.
Legal Director
Legal Action Center
Presentation Date: 06/19/2012
Release Date: 01/26/2012
Learning Objectives
- State the basic requirements of the New York State HIV confidentiality law.
- List the main exceptions to the HIV confidentiality law’s non-disclosure rule.
- Complete an HIV release form.
- Describe the legal consequences for violating the HIV confidentiality law.
Presenter Bio
Ms. Friedman directs the Center’s Legal Department, which serves over 2,500 clients annually and provides trainings and technical assistance for hundreds of health and social service program serving LAC’s constituency. Since joining the Legal Action Center in October of 1993, Sally Friedman has prosecuted cases involving the breach of HIV confidentiality and discrimination on basis of HIV status, criminal record, and drug or alcohol history. She has also advised and trained hundreds of organizations across the country on privacy and anti-discrimination laws protecting individuals with HIV, criminal records, and alcohol/drug histories. Ms. Friedman has authored numerous publications and produced video/DVD and online trainings on these topics. She is a graduate of Brown University and New York University Law School.
Continuing Education Credit
School of Public Health University at Albany is accredited by The Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
School of Public Health University at Albany designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
School of Public Health, University at Albany is an approved provider of continuing nursing education by the Massachusetts Association of Registered Nurses, Inc., an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Provider Code PA# 157N
Details
- To earn CME credit you must view all slides in the presentation.
- Each slide is tracked by the system. You can take a break from the course at any time. When you return to the course you will begin where you last left off.
- To receive CME credit, you must pass the quiz with a score of 80% or higher. You are given two attempts to pass the quiz.
- You must complete the course evaluation to receive CME credit.
- You must advance each slide manually. Use the Forward/Backward buttons or click on a slide thumbnail to navigate the presentation (see screenshot).
-
Sharon Stancliff, MD
Medical Director
Harm Reduction Coalition
Presentation Date: 12/08/2011
Release Date: 01/24/2012
Learning Objectives
- Describe the interaction of substance use and HIV medications.
- Be familiar with documented risks of substance use.
- Understand effects of Marijuana & Benozodiazepines.
- Understand possible treatment interventions.
Presenter Bio
Sharon Stancliff is the Medical Director of the Harm Reduction Coalition where she oversees SKOOP, an overdose prevention project, and runs a buprenorphine demonstration project. She is also a medical consultant for the AIDS Institute, New York State Department of Health. She has worked with drug users in methadone maintenance, primary care and at syringe exchanges and has published articles related to harm reduction and drug treatment.
Continuing Education Credit
This course is accredited by the New York State Office of Alcoholism and Substance Abuse Services for 1 continuing education credit.
School of Public Health University at Albany is accredited by The Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
School of Public Health University at Albany designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
School of Public Health, University at Albany is an approved provider of continuing nursing education by the Massachusetts Association of Registered Nurses, Inc., an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
-
Marguerite Urban, MD
Associate Professor of Medicine
University of Rochester Medical Center
Presentation Date: 10/04/2011
Release Date: 10/27/2011
Learning Objectives
- Describe the epidemiologic associations between HIV and other sexually transmitted infections (STIs).
- Describe the clinical manifestations of syphilis and how they may be altered in the setting of co-infection with HIV.
- Describe the clinical manifestations of gonorrhea and chlamydia.
Presenter Bio
Marguerite A. Urban, MD is Associate Professor in the Department of Medicine, Infectious Diseases at the University of Rochester and Medical Director, Monroe County Sexually Transmitted Diseases Clinic. Dr. Urban graduated from Medical College of Pennsylvania, and is certified by the American Board of Internal Medicine. Her research interest is related to sexual behavior, sexual risk reduction and sexual health. Dr. Urban is the author and co-author of numerous journal articles.
Continuing Education Credit
School of Public Health University at Albany is accredited by The Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
School of Public Health University at Albany designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
School of Public Health, University at Albany is an approved provider of continuing nursing education by the Massachusetts Association of Registered Nurses, Inc., an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Provider Code PA# 157N
Details
- To earn CME credit you must view all slides in the presentation.
- Each slide is tracked by the system. You can take a break from the course at any time. When you return to the course you will begin where you last left off.
- To receive CME credit, you must pass the quiz with a score of 80% or higher. You are given two attempts to pass the quiz.
- You must complete the course evaluation to receive CME credit.
- You must advance each slide manually. Use the Forward/Backward buttons or click on a slide thumbnail to navigate the presentation (see screenshot).
-
Athe Tsibiris, MD, MS
Assistant Professor of Medicine
Harvard Medical School
Presentation Date: 06/14/2011
Release Date: 06/14/2011
Learning Objectives
- Identify rates of transmitted HIV drug resistance worldwide
- Determine the optimal timing of HIV drug resistance testing
- Discuss the changing mutation patterns of HIV drug resistance
- Understand the relationship between HIV drug resistance and class-sparing regimens.
Presenter Bio
Athe Tsibris, MD, is an Assistant Professor of Medicine at Harvard Medical School, and Assistant in Medicine at the Massachusetts General Hospital. Dr. Tsibris’s research currently focuses on the characterization of HIV-1 resistance to CCR5 antagonists, and the use of ultra-deep sequencing to demonstrate dynamic HIV-1 escape from CCR5 inhibition in vivo. In addition to his translational, bench-side research, Dr. Tsibris is committed to integrating novel lab findings of HIV drug resistance to improve patient care worldwide, while continuing to be involved in clinical care and teaching.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on June 14, 2011 and will terminate June, 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Teresa Evering, MD
Associate Attending Physician
Rockefeller University Hospital
-
Martin Markowitz, MD
Aaron Diamond Professor
The Rockefeller University
Presentation Date: 06/14/2011
Release Date: 06/14/2011
Learning Objectives
- Discuss the effects of HIV-1 on the GI tract and immune reconstitution after cART is given.
- Know whether persistent CD4 depletion and immune activation in the lamina propria of the lower GI tract is due to ongoing virus replication.
- Appreciate whether 5-drug ART begun during acute and early infection results in virologic and immunologic benefit when compared to standard 3-drug ART?
Presenter Bio
Teresa Evering, MD, is an Associate Attending Physician at the Rockefeller University Hospital and Research Scientist at the ADARC, mentored by Dr. David Ho and Clinical Director of ADARC, Dr. Martin Markowitz. Dr. Evering's research has focused on questions surrounding the potential for ongoing HIV replication during suppressive highly active antiretroviral therapy, and her current work focuses primarily on the central nervous system, an important sanctuary site for HIV-1.
Presenter Bio
Martin Markowitz, MD, is Clinical Director and Staff Investigator of the Aaron Diamond AIDS Research Center (ADARC) and an Aaron Diamond Professor at The Rockefeller University in New York City. Dr. Markowitz is widely known for his research in acute and early HIV infection, HIV pathogenesis, and the development of new agents to treat HIV-1 infection.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on June 14, 2011 and will terminate June, 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Scott Letendre, MD
Associate Professor of Medicine
University of California, San Diego
Presentation Date: 05/17/2011
Release Date: 05/17/2011
Learning Objectives
- Summarize background data on differences between antiretroviral drugs in distribution into the CNS.
- Review the approach to estimating the distribution of antiretroviral regimens into the CNS.
- Review results of studies that have compared estimates of antiretroviral regimens to CNS outcomes, such as HIV RNA levels in cerebrospinal fluid or neurocognitive impairment.
- Suggest an approach to management of clinical patients for prevention and management of HAND.
Presenter Bio
Scott Letendre, M.D., is an Associate Professor of Medicine in the Department of Medicine, Division of Infectious Diseases, at the University of California, San Diego. Dr. Letendre's research, performed primarily at UCSD's HIV Neurobehavioral Research Center, focuses on the impact on the brain of chronic infections, primarily HIV and HCV, and their treatment. He is also an active investigator in the UCSD unit of the AIDS Clinical Trials Group (ACTG), and is currently a member of both the national ACTG Neurology Subcommittee and the ACTG Dementia Focus Group.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on May 11, 2011 and will terminate May, 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
David Simpson, MD, FRCP, FAAN
Professor of Neurology
Mount Sinai Medical Center
Presentation Date: 05/17/2011
Release Date: 05/17/2011
Learning Objectives
- Discuss the prevalence of neurological complications of HIV infection, with a focus on HIV neurocognitive disorders (HAND).
- Understand the clinical approach and differential diagnosis of HIV-associated central nervous system (CNS) disorders.
- Use screening and examination tools to diagnose HIV-associated CNS disorders.
Presenter Bio
David M. Simpson, MD, FRCP, FAA, is Professor of Neurology at Mount Sinai School of Medicine, Director of the Clinical Neurophysiology Laboratories, and Director of the Neuro-AIDS Program at Mount Sinai Medical Center in New York City. An author of 234 original publications and book chapters, Dr. Simpson is the principal investigator for many studies, including studies for the treatment of painful peripheral neuropathy. Dr. Simpson is a member of the American Neurological Association and the American Pain Society and is a Fellow of the American Academy of Neurology, the American Academy of Neuromuscular and Electrodiagnostic Medicine, and the Royal College of Physicians. He is on the editorial boards of AIDS Patient Care and Current HIV/AIDS Reports.
Continuing Education Credit
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
CME Information:
This CME activity was approved for AMA PRA Category One Credit™ on May 17, 2011 and will terminate May 2014.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
-
Kenneth Mayer, MD
Professor of Medicine and Community Health
Brown University
Presentation Date: 03/15/2011
Release Date: 03/15/2011
Learning Objectives
- Understand how oral antiretroviral agents may be used for pre- and post-exposure prophylaxis.
- Understand how topical antiretroviral agents may be used as microbicides to prevent HIV transmission.
- Understand the recent results of the CAPRISA 004 and iPrEx efficacy trials, and learn about upcoming chemoprophylaxis trials, and when their results will be known.
- Learn about the possibility of using novel antiretroviral agents for chemoprophylaxis.
Presenter Bio
Kenneth Mayer, MD, is Professor of Medicine and Community Health at Brown University, Director of the Brown University AIDS Program, and Attending Physician in the Infectious Diseases Division of the Miriam Hospital in Providence, Rhode Island; and Medical Research Director at Boston's Fenway Community Health Center, where (since 1983) he has conducted studies of HIV's natural history and transmission. He has co-authored over 400 articles, chapters and other publications on AIDS and related infectious disease topics, and is a frequent lecturer and presenter at national and international conferences and symposia.
Continuing Education Credit
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network, Inc. MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
-
Roy Gulick, MD, MPH
Professor of Medicine and Chief of the Division of Infectious Diseases
Weill Medical College of Cornell University in New York City
Presentation Date: 03/15/2011
Release Date: 03/15/2011
Learning Objectives
- Be aware of newer antiretroviral agents.
- Discuss the latest data on strategies for starting antiretroviral therapy and what to start with.
- Discuss the latest data on when to change antiretroviral therapy and what to change to.
Presenter Bio
Dr. Gulick is Professor of Medicine and Chief of the Division of Infectious Diseases at Weill Medical College of Cornell University in New York City. He currently serves as Principal Investigator of the Cornell HIV Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG), sponsored by the National Institutes of Health. He also serves as a Board Member of the International AIDS Society-USA, and as a member of the Panel on Clinical Practices for Treatment of HIV Infection of the U.S. Department of Health and Human Services.
Continuing Education Credit
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network, Inc. MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
-
William Valenti, MD
Clinical Associate Professor of Medicine at the University of Rochester School of Medicine and Dentistry
AIDS Care
Presentation Date: 01/18/2011
Release Date: 01/18/2011
Learning Objectives
- Understand the clinical significance of low-level viremia.
- Understand the role of Community Viral Load in HIV care.
- Understand the role of HIV treatment and undetectable viral load as prevention tools.
- Recognize advances in viral load technologies that support contemporary HIV treatment.
Presenter Bio
Bill Valenti, MD, is an internist/ infectious diseases specialist and a native of Rochester, NY. He has been doing HIV Medicine since the early 1980s, and is the Founding Medical Director of Community Health Network (now AIDS Care), a not-for-profit organization for people with HIV/AIDS, where he continues to see patients. Dr. Valenti is Clinical Associate Professor of Medicine at the University of Rochester School of Medicine and Dentistry, and is chair of the Infectious Diseases Subcommittee of Medical Society of the State of New York (MSSNY).
Continuing Education Credit
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network, Inc. MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
-
Amneris Luque, MD
Professor of Medicine, University of Rochester School of Medicine and Dentistry, and Director AIDS Center
University of Rochester Medical Center
Presentation Date: 01/05/2011
Release Date: 01/05/2011
Learning Objectives
- Describe the signs and symptoms of HIV infection
- Explain antiretroviral treatment for HIV infection
- List pretreatment considerations for HIV/AIDS patients undergoing dental procedures.
Presenter Bio
Amneris E. Luque, MD is Professor of Medicine, at the University of Rochester School of Medicine and Dentistry, and the Director of the AIDS Center at the University of Rochester Medical Center.
As an HIV/AIDS specialist Dr. Luque is devoted to both HIV clinical care and clinical education.
Dr. Luque is also the Medical Director of the NYSDOH AIDS Institute's HIV Clinical Education Initiative (CEI) in the Rochester – Finger Lakes area, and the Medical Director of the Technology Center, NYSDOH AI. She served as the Chair of the Committee for the Care of Women with HIV Infection, Chair of the NYSDOH AIDS Institute's Medical Care Criteria Committee (MCCC). Dr. Luque oversees the Quality Improvement Program at the University of Rochester Medical Center.
Continuing Education Credit
This educational activity is designated for 1.0 DCE/CE Credit.
School of Public Health University at Albany is accredited by The Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
School of Public Health University at Albany designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The New York State Dental Foundation is approved by NYSDA and the NYS Education Department as an approved provider for dental continuing education in conjunction with the New York State Dept of Health-AIDS Institute
The Dental Hygienists' Association of the State of New York, Inc., an accredited approver by the New York State Depart of Education, has approved the NY/NJ AETC's continuing education learning activities for dental hygienists
Details
- To earn DCE/CE credit you must view all slides in the presentation.
- Each slide is tracked by the system. You can take a break from the course at any time. When you return to the course you will begin where you last left off.
- To receive DCE/CE credit, you must pass the quiz with a score of 80% or higher. You are given two attempts to pass the quiz.
- You must complete the course evaluation to receive DCE/CE credit.
- You must advance each slide manually. Use the Forward/Backward buttons or click on a slide thumbnail to navigate the presentation (see screenshot).
-
John Faragon, PharmD, BCPS, AAHIVE
NY/NJ AETC Regional Pharmacy Director
Albany Medical Center
Presentation Date: 12/21/2010
Release Date: 12/21/2010
Learning Objectives
- Discuss background data on medication errors in the HIV infected population.
- Review common types and causes of medication errors that occur in the HIV population.
- Using patient cases, provide real life examples from the hospital and retail settings that describe HIV medication errors.
- Provide strategies for preventing medication errors in the HIV infected population.
Presenter Bio
John J. Faragon is currently the Regional Pharmacy Director for NY/NJ AIDS Education and Training Centers and a Pharmacist with the Department of Pharmacy at Albany Medical Center Hospital in Albany, New York.
Previously, John Faragon has held positions in pharmacy practice, academia and in the pharmaceutical industry.
He is certified in Pharmacotherapy by the Board of Pharmaceutical Specialists from the American College of Clinical Pharmacy and certified as a subject matter expert from the American Academy of HIV Medicine.
Continuing Education Credit
School of Public Health University at Albany is accredited by The Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
School of Public Health University at Albany designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Details
- To earn CME credit you must view all slides in the presentation.
- Each slide is tracked by the system. You can take a break from the course at any time. When you return to the course you will begin where you last left off.
- To receive CME credit, you must pass the quiz with a score of 80% or higher. You are given two attempts to pass the quiz.
- You must complete the course evaluation to receive CME credit.
- You must advance each slide manually. Use the Forward/Backward buttons or click on a slide thumbnail to navigate the presentation (see screenshot).
-
Thomas Schmidt, PhD, CASAC
Clinic Administrator
Suffolk County Division of Community Mental Hygiene
Presentation Date: 12/08/2009
Release Date: 12/17/2010
Learning Objectives
- Recognize the importance of alcohol screening for HIV infected patients.
- Identify at least three of the areas alcohol use/abuse impacts on clinical management of HIV.
- Define at-risk drinking, alcohol abuse, alcohol dependence, binge drinking and a "standard drink".
- State primary role, with regard to alcohol, of the clinician in the management of the patient who abuses/dependent on alcohol.
Presenter Bio
Thomas Schmidt is the Clinic Administrator of the Suffolk County Division of Community Mental Hygiene. He has been treatment provider and trainer of substance abuse treatment professionals in downstate New York for almost 30 years. His clinical experience is in the medication-assisted treatment of opioid dependence. Included in this experience was an eight year period overseeing the provision of primary medical care and case management services to HIV-infected individuals enrolled in methadone treatment programs located in Suffolk County.
Continuing Education Credit
This course is accredited by the New York State Office of Alcoholism and Substance Abuse Services for 1 continuing education credit.
Physicians - Continuing Medical Education. The School of Public Health, University at Albany, SUNY, is accredited by the Medical Society of the State of New York to sponsor continuing medical education for physicians.
The School designates this educational activity for 1.0 AMA PRA Category 1 Credit. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
School of Public Health, University at Albany is an approved provider of continuing nursing education by the Massachusetts Association of Registered Nurses, Inc., an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Details
- To earn CE credit you must view all slides in the presentation.
- Each slide is tracked by the system. You can take a break from the course at any time. When you return to the course you will begin where you last left off.
- To receive CE credit, you must pass the quiz with a score of 80% or higher. You are given two attempts to pass the quiz.
- You must complete the course evaluation to receive CE credit.
- You must advance each slide manually. Use the Forward/Backward buttons or click on a slide thumbnail to navigate the presentation (see screenshot).
-
Tae-Wook Chun, PhD
Associate Scientist
National Institute of Allergy and Infectious Diseases
Presentation Date: 11/16/2010
Release Date: 11/16/2010
Learning Objectives
- Understand the evolution of HIV reservoir research.
- Explain the impact of antiretroviral therapy on HIV reservoirs.
- Discuss the mechanisms of HIV persistence in infected individuals receiving antiretroviral therapy.
- Examine the feasibility of eradication of HIV in infected individuals receiving antiretroviral therapy.
Presenter Bio
Tae-Wook Chun received his PhD degree at the Johns Hopkins University School of Medicine in 1997. While working with Dr. Robert Siliciano at Johns Hopkins, he identified and characterized latently infected, resting CD4+ T cells in HIV-infected individuals. He conducted his postdoctoral work in Dr. Anthony Fauci's laboratory at National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH). He is currently an Associate Scientist at NIH and continues to study the role of viral reservoirs in the pathogenesis of HIV in infected individuals receiving effective antiretroviral therapy.
Continuing Education Credit
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network, Inc. MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
-
Bruce Walker, MD
Professor of Medicine
Harvard Medical School
Presentation Date: 11/16/2010
Release Date: 11/16/2010
Learning Objectives
- Better appreciate the use of genome-wide association scans to understand human disease.
- Describe the genetic basis for control and lack of control of HIV.
- Discuss the implications of genetic studies for vaccine design.
- Understand the effects of immune selection pressure on viral fitness.
Presenter Bio
Bruce Walker, MD, is Professor of Medicine at Harvard Medical School, a Howard Hughes Medical Institute Investigator, Director of the newly formed Ragon Institute of MGH, MIT and Harvard, and Adjunct Professor at the Nelson Mandela School of Medicine in Durban, South Africa. His research focuses on cellular immune responses in chronic viral infections, with a particular focus on HIV. He leads an international translational clinical and basic science research effort to understand how some rare people who are infected with HIV, but have never been treated, can fight the virus with their immune system.
Continuing Education Credit
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network, Inc. MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
-
Calvin Cohen, MD, MSc
Research Director for the Community Research Initiative of New England and Harvard Vanguard Medical Associates
Harvard Medical School
Presentation Date: 09/21/2010
Release Date: 09/21/2010
Learning Objectives
- Review data on drugs in phase 3 of development for the treatment of HIV disease.
- Describe new strategies for combining antiretroviral agents.
- Discuss data on 2-drug combinations and induction/maintenance in the treatment of HIV disease.
Presenter Bio
Calvin J. Cohen, MD, MSc is the Research Director of both Community Research Initiative of New England and Harvard Vanguard Medical Associates, and a Clinical Instructor at Harvard Medical School. Dr. Cohen's research focuses on HIV antiviral trials. He is a member of the Scientific Steering Committee of the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), an NIH-supported International network of clinician-researchers. He received the Outstanding Physician's Award by Harvard Vanguard Medical Associates, the Ebert Teaching award by Harvard Pilgrim Health Care, and the Community Recognition Award from the AIDS Action Committee of Massachusetts.
Continuing Education Credit
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network, Inc. MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
-
Todd Brown, MD, PhD
Associate Professor of Medicine
Johns Hopkins University
Presentation Date: 09/21/2010
Release Date: 09/21/2010
Learning Objectives
- Describe the action of vitamin D and the potential consequences of vitamin D deficiency.
- Define the factors associated with abnormal vitamin D metabolism in the HIV-infected patient.
- Discuss current recommendations for screening & treatment of vitamin D deficiency in HIV-infected patients.
Presenter Bio
Todd T. Brown is an Associate Professor of Medicine in the Division of Endocrinology and Metabolism at Johns Hopkins University where he is also the primary endocrine consultant to the Johns Hopkins HIV Clinic. His research focuses on metabolic, endocrine, and skeletal abnormalities observed in HIV-infected patients, particularly as related to aging. Dr Brown is Chair of the Metabolic Working Group in the Multicenter AIDS Cohort Study and was appointed by the AIDS Clinical Trial Group to their newly formed Inflammation/End-organ Disease Transformative Science Group.
Continuing Education Credit
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical Society of the State of New York (MSSNY) and the Physicians' Research Network, Inc. MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category One Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
